10.46
price up icon4.08%   0.41
after-market アフターアワーズ: 10.41 -0.05 -0.48%
loading

Vir Biotechnology Inc (VIR) 最新ニュース

pulisher
Apr 14, 2026

Vir Biotechnology Rings the Nasdaq Stock Market Closing Bell - Nasdaq

Apr 14, 2026
pulisher
Apr 14, 2026

Vir Biotechnology Rings the Closing Bell - Nasdaq

Apr 14, 2026
pulisher
Apr 14, 2026

A Look At Vir Biotechnology (VIR) Valuation After New VIR-5500 Prostate Cancer Trial Milestone - Yahoo Finance

Apr 14, 2026
pulisher
Apr 14, 2026

VIR SEC FilingsVir Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 14, 2026
pulisher
Apr 14, 2026

Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer - BioSpace

Apr 14, 2026
pulisher
Apr 14, 2026

Vir Biotechnology Q1 2025 Earnings Preview - MSN

Apr 14, 2026
pulisher
Apr 13, 2026

Vir Biotechnology doses first patient in VIR-5500 expansion trial By Investing.com - Investing.com Australia

Apr 13, 2026
pulisher
Apr 13, 2026

Vir Biotechnology (VIR) Advances Phase 1 Trial with First Patien - GuruFocus

Apr 13, 2026
pulisher
Apr 13, 2026

Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-ta - PharmiWeb.com

Apr 13, 2026
pulisher
Apr 13, 2026

Vir Biotechnology doses first patient in VIR-5500 expansion trial - Investing.com

Apr 13, 2026
pulisher
Apr 13, 2026

Vir Biotech CEO Stock Sale: $664K Transaction in April 2026News and Statistics - IndexBox

Apr 13, 2026
pulisher
Apr 12, 2026

Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 - The Motley Fool

Apr 12, 2026
pulisher
Apr 12, 2026

Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 - The Motley Fool

Apr 12, 2026
pulisher
Apr 12, 2026

VIR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 12, 2026
pulisher
Apr 10, 2026

Vir Biotechnology Announces Upcoming Chief Medical Officer Transition - TipRanks

Apr 10, 2026
pulisher
Apr 10, 2026

Vir Biotechnology (NASDAQ: VIR) Chief Medical Officer to step down April 24 - Stock Titan

Apr 10, 2026
pulisher
Apr 10, 2026

Quarterly Risk: Can Vir Biotechnology Inc be recession proof2026 Outlook & Weekly High Return Opportunities - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Vir Biotechnology (VIR) Leading with Its BiTEs Therapy - Insider Monkey

Apr 10, 2026
pulisher
Apr 10, 2026

Vir Biotechnology’s CMO Change Already Reflected in Valuation—Attention Shifts to Execution Risks for VIR-5500 - Bitget

Apr 10, 2026
pulisher
Apr 09, 2026

Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat

Apr 09, 2026
pulisher
Apr 08, 2026

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 08, 2026
pulisher
Apr 07, 2026

Vir Biotechnology CEO de Backer sells $664k in stock By Investing.com - Investing.com Canada

Apr 07, 2026
pulisher
Apr 07, 2026

Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares - MarketBeat

Apr 07, 2026
pulisher
Apr 07, 2026

Vir Biotechnology CEO de Backer sells $664k in stock - Investing.com

Apr 07, 2026
pulisher
Apr 07, 2026

Vir Biotechnology (VIR) CEO auto-sells 72,559 shares to cover RSU tax - Stock Titan

Apr 07, 2026
pulisher
Apr 07, 2026

VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick - ChartMill

Apr 07, 2026
pulisher
Apr 06, 2026

Exit Recap: What is the Moat Score of Vir Biotechnology Inc2026 Bull vs Bear & Weekly Momentum Stock Picks - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 06, 2026

VIR (NASDAQ: VIR) Form 144 shows 72,559-share sale after vesting - Stock Titan

Apr 06, 2026
pulisher
Apr 06, 2026

Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation - MSN

Apr 06, 2026
pulisher
Apr 04, 2026

VIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026
pulisher
Apr 02, 2026

Market Catalysts: Is Vir Biotechnology Inc a good stock for dollar cost averaging2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 02, 2026

Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus

Apr 02, 2026
pulisher
Apr 02, 2026

Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares By Investing.com - za.investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Vir Biotechnology (VIR) director sells 22,000 shares in open market - Stock Titan

Apr 02, 2026
pulisher
Apr 01, 2026

Vir Biotechnology (VIR) price target increased by 26.10% to 20.74 - MSN

Apr 01, 2026
pulisher
Mar 30, 2026

Energy Moves: Is Vir Biotechnology Inc stock a smart retirement pickPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Bull Bear: Is Vir Biotechnology Inc stock heavily shortedNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Investor Mood: How volatile is LGLWS stockWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 29, 2026

Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo Finance

Mar 29, 2026
pulisher
Mar 29, 2026

Why did Vir Biotechnology stock surge 60% after-hours today? - MSN

Mar 29, 2026
pulisher
Mar 27, 2026

Vanguard affiliates disaggregate holdings; VIR shows 0% ownership (VIR) - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

These analysts boost their forecasts on Vir Biotechnology - msn.com

Mar 26, 2026
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
大文字化:     |  ボリューム (24 時間):